Cryo-Cell International Inc (CCEL)
9.13
-0.25
(-2.67%)
USD |
NYAM |
May 16, 16:00
9.13
0.00 (0.00%)
After-Hours: 20:00
Cryo-Cell International Free Cash Flow: -0.8021M for Feb. 29, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
February 29, 2024 | -0.8021M |
November 30, 2023 | 1.281M |
August 31, 2023 | 2.373M |
May 31, 2023 | -4.695M |
February 28, 2023 | -3.187M |
November 30, 2022 | -8.596M |
August 31, 2022 | -9.674M |
May 31, 2022 | -0.5964M |
February 28, 2022 | -5.666M |
November 30, 2021 | 0.9749M |
August 31, 2021 | 2.528M |
May 31, 2021 | 3.700M |
February 28, 2021 | 7.908M |
November 30, 2020 | 8.017M |
August 31, 2020 | 6.057M |
May 31, 2020 | 7.047M |
February 29, 2020 | 6.436M |
November 30, 2019 | 5.632M |
August 31, 2019 | 5.469M |
May 31, 2019 | 5.390M |
February 28, 2019 | 5.254M |
November 30, 2018 | 4.687M |
August 31, 2018 | 5.950M |
May 31, 2018 | 4.512M |
February 28, 2018 | 6.432M |
Date | Value |
---|---|
November 30, 2017 | 5.620M |
August 31, 2017 | 6.070M |
May 31, 2017 | 5.970M |
February 28, 2017 | 5.000M |
November 30, 2016 | 4.645M |
August 31, 2016 | 4.060M |
May 31, 2016 | 4.005M |
February 29, 2016 | 4.508M |
November 30, 2015 | 4.743M |
August 31, 2015 | 3.025M |
May 31, 2015 | 2.937M |
February 28, 2015 | 1.858M |
November 30, 2014 | 1.434M |
August 31, 2014 | 1.073M |
May 31, 2014 | -0.1116M |
February 28, 2014 | -0.093M |
November 30, 2013 | 0.4247M |
August 31, 2013 | 0.8937M |
May 31, 2013 | 1.601M |
February 28, 2013 | 0.5389M |
November 30, 2012 | 0.2054M |
August 31, 2012 | 0.255M |
May 31, 2012 | -0.1626M |
February 29, 2012 | 0.3029M |
November 30, 2011 | 0.2246M |
Free Cash Flow Range, Past 5 Years
-9.674M
Minimum
Aug 2022
8.017M
Maximum
Nov 2020
1.480M
Average
2.450M
Median
Free Cash Flow Benchmarks
American Shared Hospital Services | -0.555M |
Novo Integrated Sciences Inc | -4.952M |
Astrana Health Inc | 52.44M |
P3 Health Partners Inc | -72.34M |
Biote Corp | 17.88M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.3569M |
Cash from Investing (Quarterly) | -0.341M |
Cash from Financing (Quarterly) | 0.539M |
Free Cash Flow Per Share (Quarterly) | -0.0987 |
Free Cash Flow to Equity (Quarterly) | -1.529M |
Free Cash Flow to Firm (Quarterly) | -0.635M |
Free Cash Flow Yield | -1.06% |